Policy Blog

This week’s digest covers mounting congressional and regulatory scrutiny of Medicare Advantage; the FDA’s launch of a unified adverse event monitoring system; back-to-back cybersecurity breaches at two major device makers; and a broad set of drug pricing, Medicaid, and NIH funding developments that will shape policy through 2027.